top of page


National Data Opt-out and what it means to cancer patients
Cancer52, together with use MY data, has produced a briefing paper entitled National Data Opt-out and what it means to cancer patients....


Cancer52 at PHE Cancer Services, Data and Outcomes Conference 2018
Cancer52 will have an active presence at the forthcoming PHE Cancer Services, Data and Outcomes Conference taking place in Manchester, 20...
Influencing the next Cancer Strategy - Members Survey
With the current Cancer Strategy set to end in 2020, Cancer52 wants to ensure that the next cancer strategy better addresses the needs of...
Influencing the next Cancer Strategy
With the current Cancer Strategy set to end in 2020, Cancer52 wants to ensure that the next cancer strategy better addresses the needs...
All Members Meeting 25 April 2018
We welcomed around 25 members to the Spring 2018 All Members Meeting, where we heard presentations from the following speakers (click on...
25 April 2018 All Members Meeting
Cancer52 is pleased to confirm the details of the next All Members Meeting as follows: Date: Wednesday 25 April 2018 Time: ...
Safeguarding interests of cancer patients during second phase of Brexit negotiations
Cancer52 has today (20 March 2018) come together with 18 other cancer charities, calling on Government to prioritise the interests of...
Consultation on updated Technology Appraisal Process Guide
On 1 March 2018, Cancer52 responded to the NICE Centre for Health Technology Evaluation's Consultation on updated Technology Appraisal...
All Members Meeting 24 January 2018
We welcomed 25 members to the first All Members Meeting of 2018, where we heard presentations from the following speakers (click on names...
24 January 2018 All Members Meeting
Cancer52 is pleased to confirm the details of the first All Members Meeting of 2018 as follows: Date: Wednesday 24 January 2018 ...
bottom of page
